Such effects were recently suggested to partially account for the IDO1-dependent immune suppression observed in human glioma (354) and were demonstrated to promote tumor growth in a melanoma mouse model (356), but it remains to be determined whether they also serve a role in different tumor types. This evidence concerns the gene IDO1 and neoplasm.